Search by Drug Name or NDC

NDC 42291-0181-01 Butalbital, Acetaminophen, and Caffeine 300; 50; 40 mg/1; mg/1; mg/1 Details

Butalbital, Acetaminophen, and Caffeine 300; 50; 40 mg/1; mg/1; mg/1

Butalbital, Acetaminophen, and Caffeine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is ACETAMINOPHEN; BUTALBITAL; CAFFEINE.

MedlinePlus Drug Summary

This combination of drugs is used to relieve tension headaches. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Related Packages: 42291-0181-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Acetaminophen, Butalbital, and Caffeine

Product Information

NDC	42291-0181
Product ID	42291-181_0e8c5472-74f3-6f18-e063-6294a90a6c04
Associated GPIs	64991003100108
GCN Sequence Number	066372
GCN Sequence Number Description	butalb/acetaminophen/caffeine CAPSULE 50-300-40 ORAL
HIC3	H3L
HIC3 Description	ANALGESIC,NON-SALICYLATE,BARBITURATE,XANTHINE COMB
GCN	28626
HICL Sequence Number	001854
HICL Sequence Number Description	BUTALBITAL/ACETAMINOPHEN/CAFFEINE
Brand/Generic	Generic
Proprietary Name	Butalbital, Acetaminophen, and Caffeine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Butalbital, Acetaminophen, and Caffeine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	300; 50; 40
Active Ingredient Units	mg/1; mg/1; mg/1
Substance Name	ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Labeler Name	AvKARE
Pharmaceutical Class	Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
DEA Schedule	CIII
Marketing Category	ANDA
Application Number	ANDA040885
Listing Certified Through	2025-12-31

Package

NDC 42291-0181-01 (42291018101)

Pricing Information	N/A
NDC Package Code	42291-181-01
Billing NDC	42291018101
Package	100 CAPSULE in 1 BOTTLE (42291-181-01)
Marketing Start Date	2014-11-24
NDC Exclude Flag	N